BDBM487581 N-(5-chloro-6-(2H-1,2,3-triazol- 2-yl)pyridin-3-yl)-1-(naphthalen- 1-yl)-5-(trifluoromethyl)-1H- pyrazole-4-carboxamide::US10954214, Compound 2
SMILES: FC(F)(F)c1c(cnn1-c1cccc2ccccc12)C(=O)Nc1cnc(c(Cl)c1)-n1nccn1
InChI Key: InChIKey=NLXGPLTWMXADNH-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (Homo sapiens (Human)) | BDBM487581 (N-(5-chloro-6-(2H-1,2,3-triazol- 2-yl)pyridin-3-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description MALT1 protease activity was assessed in an in vitro assay using a tetrapeptide as substrate and full-length MALT1 protein (Strep-MALT1(1-824)-His) pu... | US Patent US10954214 (2021) | |||||||||||
More data for this Ligand-Target Pair |